It’s promising to see evidence of clinical efficacy targeting G12D which is definitely more prevalent in cancers like pancreatic cancer. Plentiful data this meeting of duration; also let's await lasting efficacy and strategies for overcoming resistance. #AACR26 6/x https://t.co/jiWFU7DaTJ